Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Prostatic Neoplasms 3Postoperative Hemorrhage 2Neoplasms 2Kidney Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Thyroid Neoplasms 1Thromboembolism 1Surgical Wound Infection 1Spondylitis, Ankylosing 1Sleep Deprivation 1Skin Neoplasms 1Skin Diseases 1Seroma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Shivering 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Pituitary Diseases 1Ovarian Neoplasms 1Neuroinflammatory Diseases 1Neurocognitive Disorders 1Neoplasms, Fibrous Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms by Site 1Neoplasms by Histologic Type 1

Interventions

edoxaban 1Tranexamic Acid 1Sodium Chloride 1Saline Solution 1Heparin, Low-Molecular-Weight 1Enoxaparin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Thromboembolism × Sodium Chloride × Clear all
NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

University Hospital, Linkoeping

Phase 4 Completed
100 enrolled 11 charts
Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡